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Abstract: In the research of synthetic bone graft substi-
tutes, the relevance for bone regeneration can be con-
ﬁrmed in a critical-sized model. In this study the rabbit
radial defect was investigated as an ingenious model of
critical size, due to its defect immobilizing intact ulna. In
addition, the inﬂuence of poly(DL-lactic-co-glycolic acid)
(PLGA) on bone regeneration was determined. Sixteen, 4-
month-old rabbits received bilateral segmental radial
defects of 15 or 20 mm. The osteotomy ends were marked
with small titanium pins. Half of the group received
injected PLGA microparticle/carboxymethylcellulose im-
plants. Implantation time was 12 weeks. Evaluation con-
sisted of radiographs after surgery and sacriﬁce, micro-
computed tomography and histology. The radiographs
revealed that the created defects were signiﬁcantly smaller
after sacriﬁce. Further a number of radii showed ﬁbrocarti-
laginous interposition. Both ﬁndings indicated instability
of the created defect. All evaluation techniques revealed
that 15 and 20 mm were not of critical size, as most defects
were more or less regenerated. PLGA microparticles did
not inﬂuence bone regeneration signiﬁcantly. In conclu-
sion, 15- and 20-mm radius defects in 4-month-old rabbits
were not a suitable model for bone regeneration as these
defects were neither critical size nor stable. PLGA-micro-
particle degradation did not inﬂuence bone regeneration.
 2007 Wiley Periodicals, Inc. J Biomed Mater Res 85A:
206–217, 2008
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INTRODUCTION
Long bone segmental defects remain a difﬁcult
clinical problem to manage.1 Synthetic bone graft
substitutes are expected to be of major importance in
the treatment of these large bone defects. However,
the osteoregenerative potential of these bone substi-
tutes still needs to be improved to obtain materials
equivalent to autologous bone.
In the evaluation of artiﬁcial bone regenerative
materials, the so-called ‘‘critical-size defect’’ (CSD) is
an essential model. A CSD is deﬁned as the smallest
size of a defect, that does not heal spontaneously
when left untreated for a certain time period2 or that
shows less than 10% bone regeneration during the
lifespan of an animal.3 The effectiveness of bone
graft substitutes in bone regeneration can be proven
when the materials overcome the nonhealing of criti-
cal-sized bone defects. Several CSD models in differ-
ent animals have already been described, each with
their own speciﬁc application. For instance, calvarial
defects in rats and rabbits provide good ﬁrst phase
nonload bearing bone models with relative biological
inertness due to poor blood supply and limited bone
marrow, resembling atrophic mandibular bone in
humans.3 A good site for studying the regeneration
of segmental long bone defects is the mid-diaphyseal
radius. It is claimed that this model does not need
internal ﬁxation or external splinting in small ani-
mals as the adjacent intact ulna provides stability to
the created radial defect.4–9 Consequently, operation
time and costs are minimized and the risk of infec-
tion is reduced. For ﬁrst phase research, before large
animal implantation, rabbits are interesting as exper-
imental animals, as their bones are large enough to
evaluate material handling properties in comparison
to rats for instance. However, a review of the litera-
ture shows that the exact critical size of radial
defects in rabbits is not clear.4,5,7,10–13 Disregarding
study dissimilarities, it varies between 10 and 20 mm
in general. Earlier studies in our laboratory investigated
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polymeric scaffolds for degradation and bone forma-
tion in 15-mm segmental radial rabbit defects.6,14
Although the model was found to be suitable to test
these scaffold materials, empty defects did not con-
ﬁrm a critical size of 15 mm for a time period of 12
weeks, because some of the defects had closed. Cur-
rently, analysis techniques mainly consist of radio-
graphs and histology. Because of the two-dimen-
sional nature of these techniques, localization and
quantiﬁcation of newly formed bone in and around
a defect site can be difﬁcult. A more complete analy-
sis can be done using three-dimensional images pro-
vided by microcomputed tomography (lCT)15–17 for
example. In the present study, the critical size for
mid-diaphyseal radial defects in rabbits was
assessed by radiographs, lCT images, and histology.
Besides determining the critical size of a radial
defect, the rationale for the current study was to
evaluate poly (DL-lactic-co-glycolic acid) (PLGA) for
its inﬂuence on bone regeneration. Our laboratory
focuses on calcium phosphate cement as an artiﬁcial
bone regenerative material. To obtain an injectable
and degradable biomaterial, microparticles of PLGA
are added. The microparticles initially stabilize the
paste but will also degrade over time, leaving mac-
ropores behind. Subsequently, these macropores can
improve the degradation rate of the cement, similar
to that shown by del Real et al.18 for a non-in vivo
injectable CO2-induced macroporous cement placed
in trabecular bone defects in goats, as a result of
increased speciﬁc surface area and enhanced tissue
ingrowth into the material porosity. Besides acting
as a porogen, PLGA can also be used as a delivery
vehicle for growth factors19–21 in order to further
enhance the bone regenerative effect of the calcium
phosphate cement. PLGA is a biodegradable poly-
mer, used clinically in suture material and is consid-
ered to be biocompatible.22,23 The polymer degrades
by random hydrolysis into nontoxic lactic and gly-
colic acids which are eliminated from the body
through respiration and excretion in the urine.21,24,25
Although PLGA is claimed to be biocompatible, the
degradation of PLGA is associated with the release
of acidic degradation products.24,26 Therefore, the
current study focused on PLGA as a possible para-
meter inﬂuencing bone regeneration. Carboxymethyl-
cellulose (CMC) was used as a carrier biomaterial
for the PLGA microparticles. The polysaccharide-
based hydrogel is biocompatible21,27 and is known to
provide good plasticity as well as good space-keep-
ing properties.28,29 This carrier material has been
reported to not interfere with osteogenesis.29–31
In view of what has been mentioned earlier, the
rationale for the current study was to investigate the
mid-diaphyseal radial defect in rabbits as a critical-
size model. In addition, the regenerative capacity of
a composite of PLGA microparticles in CMC was
investigated in this segmental bone defect model.
We hypothesized that PLGA would not inﬂuence
bone regeneration.
MATERIALS AND METHODS
Preparation of PLGA microparticles
PLGA (Purasorb1, Purac, Gorinchem, The Netherlands)
with a lactic to glycolic acid copolymer ratio of 50:50 and a
molecular weight of 48.0 6 1.6 kg/mol was used to pre-
pare microparticles with a double-emulsion-solvent-extrac-
tion technique ([water-in-oil]-in-water).19,26,32–34 This con-
sisted of the injection of 500 lL distilled water into a tube
containing a solution of 1.0 g PLGA in 4 mL dichlorome-
thane. This mixture was emulsiﬁed for 60 s on a vortexer.
Then 6 mL 0.3% aqueous poly(vinyl alcohol) (PVA, Acros
Organics, Geel, Belgium) solution was added and emulsi-
ﬁed for another 60 s to produce the second emulsion. This
mixture was added to 394 mL 0.3% PVA solution and
400 mL of 2 % isopropylic alcohol solution and was stirred
for 1 h. The evaporation of the solvent resulted in precipi-
tation of the dissolved polymer and the subsequent forma-
tion of microparticles. The microparticles were allowed to
settle for 15 min and the solution was decanted. Then, the
microparticles were collected through centrifugation at
1500 rpm for 5 min, lyophilized to dryness and stored
under argon at 208C until use. Size distribution of the
PLGA microparticles was determined by image analysis
(Leica Qwin1, Leica Microsystems). The PLGA micropar-
ticles were sterilized by glow discharge (Plasma cleaner/
sterilizer, Harrick Scientiﬁc, Ossining, New York, USA).
Preparation of injectable PLGA implant
The polysaccharide-based hydrogel CMC (cekol 50.000)
(Noviant BV, Nijmegen, the Netherlands) was used as a
carrier material for the PLGA microparticles. CMC powder
was sterilized by glow discharge. The powder (4%) was
mixed with sterile distilled water according to the manu-
facturer’s instructions in order to form a gel with a putty-
like appearance. Prior to surgery the PLGA microparticles
were added to the CMC solution in a 20 wt% ratio, as pilot
studies performed in our laboratory (unpublished data)
had shown that this ratio provided an injectable material
with good consistency and homogeneous divided micro-
particles. The PLGA/CMC composite was injected into the
mid-diaphyseal radial defects using a 1 mL syringe
(Becton & Dickinson, USA) with a 4.7-mm diameter and
the tip cut off.
Surgical procedure
Sixteen healthy 4-month-old (about 16 weeks) female
New Zealand White rabbits, with a weight of 2.7–3.4 kg
were included in this study. National guidelines for the
care and use of laboratory animals were observed. All ani-
mals were screened for good physical condition.
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The operation was performed under general inhalation
anesthesia. The anesthesia was induced by an intravenous
injection of Hypnorm1 (0.315 mg/mL fentanyl citrate and
10 mg/mL ﬂuanisone; Janssen Pharmaceutica, Beerse, Bel-
gium) and atropine and maintained by a mixture of ni-
trous oxide, isoﬂurane, and oxygen through a constant vol-
ume ventilator. The rabbits were connected to a heart
monitor. To reduce perioperative infection risk, antibiotic
prophylaxis was given (Baytril1 2.5% enroﬂoxacin, 5–10
mg/kg; Bayer Healthcare, Mijdrecht, the Netherlands).
The rabbits were immobilized on their abdomen. Both
forelimbs were shaved, washed, and disinfected with povi-
done–iodine. A 4.5-cm longitudinal incision was made
along the radius. After dissecting the muscles and expo-
sure of the radius, a segmental defect of 15 or 20 mm was
created in the middle of the radius using a dental burr
(Elcomed 100, W&H Dentalwerk Burmoos GmbH, Austria)
with a diamond blade (Horico, Berlin, Germany) at a rotat-
ing speed of 800 rpm and under continuous saline cooling.
A titanium rod of 15 or 20 mm was used to obtain defects
with standardized size. The periosteum was resected with
the bone segment and the intervening membrana interos-
sea was removed as well. The osteotomy ends were
marked with titanium bone markers (Stabilok1, Fairfax
Dental, Ireland) at a distance of 7 mm from the bone edge.
Four experimental groups were speciﬁed (15-mm open
defect, 20-mm open defect, 15-mm defect with PLGA
implant, and 20-mm defect with PLGA implant) and the
animals were randomly assigned to one of these groups
(Table I). The implant consisting of the PLGA/CMC com-
posite was injected into the defects using a 1-mL syringe
(Becton & Dickinson) with a 4.7-mm diameter and the tip
cut off (Fig. 1). The implant retained its shape in accord-
ance with the defect size due to its putty-like appearance.
No additional ﬁxation was used for the implants. Finally,
the soft tissues were closed in separate layers using resorb-
able Vicryl1 4.0 (Johnson and Johnson, St. Stevens-
Woluwe, Belgium) sutures. The surgical procedure was
identical on both sides. An X-ray of both forelimbs was
made immediately after surgery (Mobilett X-ray machine,
Siemens, Munich, Germany) and the distance between the
Ti-markers was measured.
To minimize postoperative discomfort, Finadyne1
(Schering-Plough, Segre, France) 1 mg/kg was adminis-
tered intramuscularly preoperatively and was continued
for 2 days after surgery. Some contradiction about the use
of this nonsteroidal antiinﬂammatory drug (NSAID) in
bone surgery exists, as bone repair could possibly be
impaired.35 However, as in humans these drugs are a
standardized postoperative regimen for pain relief,36 we
believe that administration in our experimental animals is
justiﬁed.
The animals were housed individually in cages and
were observed for signs of pain, infection, and proper
activity. Twelve weeks after surgery the rabbits were sacri-
ﬁced by an intravenous injection of Nembutal (pentobarbi-
tal) (CEVA Sante Animale BV, Libourne, France).
Radiographs
After sacriﬁcing the animals, the radii were retrieved
immediately and excess soft tissue was removed. Radio-
graphs were made (Mobilett X-ray machine, Siemens, Mu-
nich, Germany) and evaluated using a modiﬁed system to
score defect bridging and bone formation16 [Fig. 2(A,B)].
The distance between the Ti-markers was also measured.
Microcomputed tomography
Subsequently, any excess of bone was cut off with a dia-
mond saw and the specimens were ﬁxed in phosphate-buf-
fered formaldehyde solution (pH ¼ 7.4) and dehydrated in
ethanol 70%. Then, lCT was performed to analyze defect
bridging and bone volume. The specimens were wrapped
TABLE I
Implantation Scheme Indicating for Each Rabbit and
Limb Side the Defect Size and Type of Group Consisting
of () Open Defect or (þ) PLGA Implant
Rabbit No. Right Limb Left Limb
1 20 mm  20 mm þ
2 20 mm þ 20 mm 
3 20 mm  20 mm þ
4 20 mm þ 20 mm 
5 15 mm  15 mm þ
6 15 mm þ 15 mm 
7 15 mm  15 mm þ
8 15 mm þ 15 mm 
9 15 mm  15 mmþ
10 15 mm þ 15 mm 
11 15 mm  15 mm þ
12 15 mm þ 15 mm 
13 20 mm  20 mmþ
14 20 mm þ 20 mm 
15 20 mm  20 mm þ
16 20 mm þ 20 mm 
Figure 1. A segmental mid-diaphyseal radial defect in
the forelimb of a rabbit with a PLGA microparticle/CMC
composite injected into the defect. [Color ﬁgure can be
viewed in the online issue, which is available at www.
interscience.wiley.com.]
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in Paraﬁlm M1 (Pechiney Plastic Packaging, Chicago,
USA) to prevent drying during scanning. Thereafter, all
samples were scanned at a voltage of 101 kV and intensity
of 96 lAwith a resolution of 18.69 lmusing an aluminum ﬁl-
ter (1 mm) (Skyscan-1072 X-ray microtomograph, TomoNT
version 3N.5, Skyscan1, Belgium). Cone-Beam reconstruc-
tion (version 2.15, Skyscan1) was performed. All scanning
and reconstruction parameters applied were identical for
all specimens.
Three-dimensional images were created using 3D-crea-
tor (version 2.2h, Skyscan1). These images were scored for
defect bridging with the same modiﬁed scoring system as
used for the radiographs16 [Fig. 2(A)]. The data were then
further analyzed by CT Analyzer (version 1.4, Skyscan1).
The region of interest was speciﬁed as a area of 16.87 mm2
covering the ulna and radial defect over a length of 1 mm
proximal to 1 mm distal of the osteotomy ends (Fig. 3). In
this area bone volume (mm3) was calculated for the ulna
and regenerated radius, because it was impossible to dis-
tinguish between ulnar and regenerated radial bone. To
quantify radial bone formation over time, radial defects
were created in reference forelimbs (n ¼ 4) of rabbits with
identical weight and age (7 months old) as the experimen-
tal group, to determine the amount of ulnar bone. This av-
erage amount of ulnar bone in the reference rabbits was
subtracted from the total (radial and ulnar) amount of
bone after 12 weeks implantation to determine the amount
of newly formed radial bone.
Histological procedures
After lCT was performed, the specimens were dehy-
drated in increasing ethanol concentrations (70–100%) and
embedded (nondecalciﬁed) in methylmethacrylate. After
polymerization, the specimens were hemisectioned through
the center of the defect creating two halves. Thin sections
(10 lm) were prepared in a transverse direction of one
half and a longitudinal direction of the other part using
Figure 2. Modiﬁed scoring system for the quantitative
evaluation of radiographs and lCT images. (A) Degree of
bridging. Values refer to the percentage of contact surface
of bridged bone at each side of the defect. (B) Bone forma-
tion in the defect. Values refer to the percentage of the
defect area that is ﬁlled with bone. A score of zero was
used when no bone bridging or bone formation was
found.
Figure 3. The region of interest as speciﬁed with CT Ana-
lyzer shown in a reference forelimb with a 15-mm radial
defect. A area of 16.87 mm2 covered the radial defect and
ulna over a length of 1 mm proximal to 1 mm distal from
the osteotomy sites.
Figure 4. Size distribution of the PLGA microparticles
prepared by a double-emulsion-solvent-extraction tech-
nique (group size ¼ 166).
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a microtome with a diamond blade (Leica Microsystems
SP 1600, Nussloch, Germany). The sections were stained
with methylene blue and basic fuchsin. The histological
evaluation consisted of a morphological description of at
least three sections of each implant using a light micro-
scope (Leica Microsystems AG, Wetzlar, Germany).
Statistical Analysis
Statistical analyses were performed with GraphPad1
Instat 3.05 software (GraphPad Software, San Diego, CA,
USA) and SPSS (version 12.0.1, Chicago, USA). For com-
parison of the distance between the Ti-markers after sur-
gery and sacriﬁce an unpaired t-test was used. The scoring
of defect bridging and bone formation of the radiographs
as well as defect bridging of the lCT images was analyzed
with chi-square tests. lCT bone volume was evaluated
with an unpaired t-test with Welch correction. Differences
were considered signiﬁcant at p-values less than 0.05.
RESULTS
Characterization of PLGA microparticles
Figure 4 shows the size distribution of the PLGA
microparticles prepared by a double-emulsion-sol-
vent-extraction technique. The average size of the
microparticles was 29 6 22 lm, as determined by
image analysis (Leica Qwin1, Leica Microsystems).
Macroscopical evaluation
All rabbits recovered from the surgical procedure
well and in general no complications were encoun-
tered. One rabbit developed an infection unilaterally;
this specimen was excluded from further analysis
(20-mm defect with PLGA implant).
Radiographs
The X-rays made immediately after surgery con-
ﬁrmed that the created defects were indeed 15 (15.3
6 0.6) and 20 mm (20.7 6 0.6) in size. The epiphy-
seal plates at this time point were not completely
closed.
Figure 5. Representative X-rays of a 15-mm defect after
surgery (A) and sacriﬁce (B). The distance between the Ti-
markers was signiﬁcantly reduced after sacriﬁce.
TABLE II
Results of the Radiographic Scoring for the Degree of Defect Bridging and the Amount of Bone Formation in 15 and
20-mm Defects With and Without PLGA Implants
Defect Bridging Bone Formation
15 mm
No implant 2.4 6 1.6 (4, 0, 1, 1, 2, 3, 4, 4) 2.6 6 1.3 (4, 1, 1, 2, 2, 3, 4, 4)
Implant 2 6 1.4 (1, 4, 1, 1, 1, 3, 4, 1) 2.4 6 1.2 (2, 4, 2, 2, 1, 3, 4, 1)
20 mm
No implant 2.8 6 1.4 (4, 3, 3, 2, 4, 4, 0, 2) 3 6 1.2 (4, 4, 3, 2, 4, 4, 1, 2)
Implant 2 6 0.8 (1, 2, 2, 2, 3, 1, 3) 2.4 6 0.8 (1, 3, 3, 2, 3, 2, 3)
Data represent the mean and standard deviations followed by the score per specimen. No signiﬁcant differences among
the groups were found.
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After retrieval of the specimens, the distance
between the Ti-markers, placed 7 mm from the oste-
otomy ends, was measured. The distance in all the
15-mm defects as measured after sacriﬁce (26.9 6 1.4
mm) was signiﬁcantly (p < 0.01) lower as compared
to the postoperative distance (28.4 6 1.2 mm) (Fig. 5).
Also for the 20-mm group the defect size after
sacriﬁce (32.4 6 1.2 mm) was signiﬁcantly (p < 0.001)
smaller as compared to the postoperative size (33.9
6 0.9 mm) (unpaired t-test). The epiphyseal plates
were closed now, but remnants were still visible
indicating that the closure had just occurred.
The results of radiographic scoring with the modi-
ﬁed scoring system of defect bridging and bone for-
mation are depicted in Table II. The 15 as well as
the 20-mm defect size appeared not to be a critical
size, as most defects showed bridging of the bone
defect (score 2.4 6 1.6 for 15-mm and score 2.8 6 1.4
for 20-mm defects). No signiﬁcant differences in
defect bridging or degree of bone formation were
found between the groups with and without PLGA
implants and between the 15-mm group compared
to the 20-mm group (chi-square tests).
lCT images
The results of lCT scoring with the modiﬁed scor-
ing system of defect bridging are depicted in Table
III. Conﬁrming the radiographic ﬁndings, both defect
sizes were not of critical size, as score zero [Fig.
6(A)] was only found in a minority of the radii that
received no implant. No signiﬁcant difference in
defect bridging was found in the 15- as well as the
20-mm groups between defects with and without
PLGA implantation. Also defect bridging did not
signiﬁcantly differ between the 15- and 20-mm
groups (chi-square tests).
Comparison of the scoring of the radiographs or
three-dimensional lCT images revealed no signiﬁ-
cant difference in defect bridging between these two
evaluation techniques (chi-square tests). However,
the lCT images allowed for a more precise evalua-
tion of bone regeneration in the defects. Different
kinds of bridging could be distinguished, including
a normal or atypical radius contour [Fig. 6(B,C)],
which could not be identiﬁed in the two-dimensional
radiographic pictures. No signiﬁcant differences in
prevalence of these contours between the defects
with or without an implant or between the 15- and
20-mm group were found (chi-square tests). The
TABLE III
Results of the lCT Scoring for the Degree of Defect
Bridging in 15 and 20-mm Defects With and Without
PLGA Implants
Defect Bridging
15 mm
No implant 1.9 6 1.6 (4, 0, 0, 1, 2, 3, 1, 4)
Implant 2.6 6 1.7 (1, 4, 4, 3, 0, 4, 4, 1)
20 mm
No implant 2.8 6 1.6 (4, 3, 2, 1, 4, 4, 0, 4)
Implant 2.1 6 1.2 (1, 2, 1, 1, 3, 3, 4)
Data represent the score per specimen followed by mean
and standard deviations. No signiﬁcant differences among
the groups were found.
Figure 6. lCT images of radial defects after 12 weeks of implantation: (A) nonbridging, (B) normal radius contour bridg-
ing, and (C) atypical radius contour bridging.
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lCT images also revealed nonunion of the regener-
ated radius in three specimens of the 20-mm group,
characterized by nonalignment of the newly formed
bone (Fig. 7).
The results of bone volume (mm3) in the ulnar
and radial region as determined by lCT are depicted
in Table IV. As a reference for ulnar bone, the
amount of ulnar bone was measured in the forelimbs
of 6-month-old reference rabbits with a radial defect.
In the 15-mm defects, the bone volume had signiﬁ-
cantly increased after 12 weeks implantation in the
defects with and without a PLGA implant as com-
pared to the reference defects (p < 0.0001, unpaired
t-test with Welch correction). This indicates that the
amount of newly formed bone in the defect was sig-
niﬁcantly increased compared to the direct postoper-
ative situation. There was no signiﬁcant difference
between the 15-mm group with or without an
implant (unpaired t-test). Also in the 20-mm defects,
bone volume had increased signiﬁcantly after 12
weeks of implantation as compared to the reference
20-mm defects (p < 0.0001, unpaired t-test with
Welch correction) and no signiﬁcant difference
existed between the 20-mm defect group with and
without a PLGA implant (unpaired t-test).
Histology
Gross analysis of the histological sections with
light microscopy revealed that in general the tissue
reaction was uniform in all specimens, independent
of the defect size or the implantation of PLGA. The
osteotomy ends could easily be identiﬁed. In the
specimens that received PLGA microparticles no
remains of the implant were found after 12 weeks of
implantation. Further, no inﬂammatory reaction was
seen at this time point, as no inﬂammatory cells or
intervening ﬁbrous tissue were noticed.
The longitudinal sections revealed that most speci-
mens showed regeneration of the radius. Bone had
formed out of the osteotomy ends or was located at
the ulnar surface. Fusion of ulnar and radial bone
was seen in almost all samples. The degree of bone
remodeling varied between the specimens. Some
showed compact newly formed bone, while in other
regenerated defects bone marrow formation was
apparent (Fig. 8). No difference in the occurrence of
this remodeling was found between the groups.
In three 20-mm defects, nonunion was observed
between the radial osteotomy end and regenerated
bone [Fig. 9(A,B)], as characterized by ﬁbrocartilagi-
nous interposed tissue. Histology also revealed carti-
lage tissue located in the area between the ulna and
radius [Fig. 9(C)]. This type of nonunion was found
Figure 7. lCT image of a 20-mm defect with an implant
after 12 weeks of implantation, showing nonunion.
TABLE IV
The Volume of Bone in the Ulnar and Radial Region (mm3) as Determined With lCT
15 mm 20 mm
Reference Subject Reference Subject
No implant 141.7 6 9.7 252.3 6 38.1* 180.3 6 22.3 336.6 6 39.5*
PLGA implant 263.5 6 40.3* 328.2 6 27.9*
Data represent the mean and standard deviations. Bone formation was signiﬁcantly (*) increased compared to the refer-
ence groups. No signiﬁcant differences were found between the groups with and without a PLGA implant.
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in six of sixteen 20-mm defects and seven of ﬁfteen
15-mm defects.
Bone regeneration not only occurred at the radial
osteotomy ends. The transverse sections frequently
showed that the ulnar bone had undergone consider-
able remodeling and hypertrophy (Fig. 10).
DISCUSSION AND CONCLUSION
Critical-size defects are important to evaluate the
bone regenerative effect of artiﬁcial bone graft sub-
stitutes. In the present study, segmental mid-dia-
physeal radial defects of 15 and 20 mm were created
in the forelimbs of 4-month-old New Zealand White
rabbits to determine whether this defect size was
critical after 12 weeks of implantation. In addition,
an implant consisting of PLGA microparticles in a
carrier material of CMC was examined for its inﬂu-
ence on bone regeneration. Both defect sizes turned
out not to be of critical size. Moreover, defect insta-
bility was noticed. PLGA/CMC composites did not
have a signiﬁcant effect on bone formation.
The rabbit radius is often used as model for the
evaluation of bone regeneration. Defect sizes in the
range of 10 to 20 mm have been described as being
of critical size in a series of studies.4,5,7,10–13 In the
present study, however, a radius defect of 15 as well
as of 20 mm regenerated after 12 weeks of implanta-
tion. There are several variables during the study pe-
riod that can explain this difference in bone regener-
ation, including the animals, operation technique,
implantation time, and the evaluation of the data.
Figure 8. Histological longitudinal section of a 15-mm
radius defect with a PLGA implant. The radial bone (R)
has regenerated and bone marrow (BM) has formed. OE,
radial osteotomy end; U, ulnar bone. Methylene blue and
basic fuchsin staining. [Color ﬁgure can be viewed in the
online issue, which is available at www.interscience.wiley.
com.]
Figure 9. Histological longitudinal sections showing nonunion (A) in the regenerated radius of a 20-mm defect with an
implant with the (B) magniﬁcation of the ﬁbrocartilaginous interposition. (C) Nonunion located in the area between the
ulna and radius of a 15-mm defect without an implant. R, radius; U, ulna. Methylene blue and basic fuchsin staining.
[Color ﬁgure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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Starting with the experimental animals, age might
be an important factor in bone regenerative behav-
ior. In the present study, 4-month-old rabbits were
included. Previous studies dealing with critical-sized
diaphyseal radial defects did not mention the age of
the rabbits4,7,13 or only cited that the epiphyseal
plates were closed on radiographs.5,10,11 It has to be
noticed that, besides epiphysis obliteration, the age
of the rabbits has to be provided as discrepancy
exists in radiographic and histological epiphyseal
closure37 and in closure of different epiphyses within
the same animal or even at the opposite ends of the
same bone.38 Although by 16 weeks of age long
bones have reached about 95% of their adult length
in rabbits,38 the skeletal growth of New Zealand
White Rabbits is complete between 19 and 32
weeks.37,39 Therefore, it can be supposed that the
animals as used in our study were not mature
enough and still possessed a high potential of regen-
eration similar to newborn animals.3,40,41 In view of
this, the use of rabbits older than 6 months should
be recommended for bone regenerative studies.
Besides the animal model, the surgical technique
used could have affected defect regeneration. Gentle
drilling under saline cooling will result in better
regeneration compared to more brutal techniques,
which might destroy bone tissue. In addition, it is
conceivable that the experience and skill of the sur-
geon are also associated with bridging of the defect.
In our study, the periosteum and interosseous mem-
brane were removed, as these could accelerate bone
regeneration.42 However, an opposite effect of this
tissue removal might have occurred. Frequently, ul-
nar hypertrophy was observed, which might have
been caused by scratching of the ulnar bone surface.
Simon et al.43 studied the effect of incising the tibial
bone surface in goats and found that cambium cells
were stimulated, resulting in callus matrix synthesis.
In addition, O’Driscoll et al.44 outlined the complex-
ity of periosteal harvesting in rabbits, as the cam-
bium layer is only lightly adherent to the ﬁbrous
layer and can easily be left behind when the perios-
teum is harvested. Hypothetically, in the present
study with the removal of periosteal tissue, cambium
cells might have remained and the removal process
may have stimulated these cambium cells and
induced osteogenesis. In previous studies, ulnar hy-
pertrophy was not mentioned or ulnar bone growth
was not deﬁned as defect bridging.5,7 Nevertheless,
the effect of cambium cell stimulation might be triv-
ial in older rabbits as the cambium cells diminish
with age.45
The implantation time can play a role as well.
Some studies showing nonbridging of rabbit radial
defects used implantation times of 4–8 weeks4,10,11,13
instead of 12 weeks as used in the present study. It
might be that the period between 8 and 12 weeks
enclosed the critical transition to closure of the
defect. As described in the Introduction, the deﬁni-
tion of a CSD encloses a time span. Hypothetically,
small bone defects will not heal spontaneously when
the lifetime of experimental animals is short enough.
To fulﬁll the deﬁnition of a CSD, however, the ani-
mal lifetime should enclose at least a complete bone
remodeling cycle.3 Bone remodeling in humans takes
about 2 to 8 months,46 in animals this can be
shorter.40 We therefore recommend a study period
of at least 12 weeks for the evaluation of bone for-
mation in CSD models.
Finally, differences occur in the evaluation of the
data between various studies, which can result in
different conclusions about bridging of created bone
defects. As mentioned before, ulnar hypertrophy is
not always considered as defect bridging.5,7 Also a
less stringent scoring system leads to fewer defects
rated as nonbridged.10 Further, three-dimensional
evaluation of bone bridging using additional lCT
images is more accurate than two-dimensional eval-
uation techniques using radiographs and histology
alone.16 The present study conﬁrmed this, as each
evaluation technique has its own contribution to the
evaluation of the data. lCT images revealed several
types of defect bridging which could not be detected
with radiographs alone. Further, the histological sec-
tions exposed nonunion, which was not always visi-
ble in the lCT images.
One of the reasons why the rabbit radius is a fa-
vorite model for evaluating bone regeneration is that
the intact adjacent ulna is supposed to provide sta-
bility to the created radial defect without the need
for internal or external ﬁxation of the forelimb.4–8 In
our study it was possible to measure the actual
defect size after surgery and sacriﬁce, as we marked
the osteotomy ends with titanium. According to our
Figure 10. Cross-sectional photomicrograph of a 15-mm
radial defect without a PLGA implant. Ulnar hypertrophy
can be noticed (*). U, ulna; R, regenerated radius. Methyl-
ene blue and basic fuchsin staining. [Color ﬁgure can be
viewed in the online issue, which is available at www.
interscience.wiley.com.]
214 BODDE ET AL.
Journal of Biomedical Materials Research Part A
knowledge, comparison of the postoperative and
post-sacriﬁce defect sizes has not been done before.
We noticed that the distance between the titanium
markers became signiﬁcantly shorter after 12 weeks
of implantation in the 15- as well as the 20-mm
group. In addition, nonunion was found in several
regenerated defects of both groups. These ﬁndings
indicate that the ulna was not able to immobilize the
created radial defect optimally.47 Evidently, the rab-
bit radius is not a suitable model for bone regenera-
tion, without additional ﬁxation of the osteotomy
ends, beyond the discussion whether the defect sizes
are critical or not.
Another known critical-size long bone model is
the rabbit femur.48 In this model, however, the use
of osteosynthesis material such as screw plates and
intramedullar Kirschner wires is unavoidable. Con-
sequently, infection risk and interference in bone
regeneration cannot be excluded. The search for new
self-stabilizing bone defects in rabbits is of interest
for future synthetic bone graft investigations as im-
plantation in a validated small animal model is a
prerequisite before large animal implantation.49 So
far, only the 15-mm calvarial defect seems to be a
reliable CSD model complying with these requisites
in rabbits.3,50,51 In goats the os ilium has shown
potential for producing critical-sized defects.51 This
ilium model might also be engaged in rabbits.
PLGA microparticles were examined in this study
for their inﬂuence on bone regeneration. After 12
weeks of implantation no remnants of the PLGA
implant were found in the histological sections.
PLGA degrades by hydrolytic cleavage of its polymer
chains.22 The protons released during degradation
can cause acidity, which can result in inﬂammation
and tissue necrosis when the clearance of the degra-
dation products is not adequate24 or due to a delay
in further metabolism to carbon oxide and water.25
In the present study, no differences in bone forma-
tion or inﬂammation were found between control
and implant groups after 12 weeks of implantation.
The effect of acidity is apparently negligible for
small amounts of PLGA in microparticle form,
although it has to be mentioned that the biochemical
and mechanical aspects of the newly formed bone
were not examined in the present study. The ﬁnding
of negligible acidity agrees with clinical studies in
patients, where porous or sponge-like PLGA root
replicas were well tolerated in post-extraction alveo-
lar socket healing.52,53 In contrast, dense PLGA
implants caused an initial temporary lactic acid
induced decalciﬁcation of the alveolar process.52
Nevertheless, it has to be noted that the mechanism
of PLGA-microparticle clearance is not known in the
current study, as no short-term follow-up was per-
formed. The mechanisms involved could include
degradation, dissolution or even migration, with the
latter resulting in a possible false neutral inﬂuence
on bone regeneration.
In conclusion, CSD models are important for the
evaluation of synthetic bone grafts, but the radius of
four month old New Zealand White Rabbits is not a
suitable location for this model, because 15- and
20-mm defects were not of critical size and no stable
defect could be created. PLGA-microparticle degra-
dation did not inﬂuence bone formation.
The CMC used in this study was kindly provided by
Noviant BV, Nijmegen, the Netherlands. The authors
would like to thank Dr. Ir. E. Bronkhorst for his assistance
with statistical analysis and S. Young for critically reading
the manuscript.
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